Drawing for LUMIRA HEALTHCARE

USPTO serial 99261613

LUMIRA HEALTHCARE

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
Examiner
ATTANG, UDEME U
Law office
TMO LAW OFFICE 115

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with LUMIRA HEALTHCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Retail pharmacy servicesACTIVE
044Health care services, namely, providing primary care medical services, preventive medical care, dental care, behavioral health services, telehealth services offering medical consultations provided via phone, online chat or video conferencing, and pharmacy services being preparation of prescriptions in pharmacies; Medical services; Telemedicine servicesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 2, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jun 2, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 2, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 26, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 2, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2025DOCKASSIGNED TO EXAMINER
Nov 6, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 6, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Jul 1, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance